Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...
An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...
Phase 2 trial shows sorfequiline with pretomanid and linezolid may enhance TB treatment efficacy and safety for drug-sensitive patients.
News-Medical.Net on MSN
New clinical trial shows promise for shorter TB treatment
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
Statista on MSN
Drug-Resistant TB Slows Path to Global 90% Target
This chart shows the share of people diagnosed with tuberculosis (TB) who were cured/completed their treatment, by TB type (in %)*.
Researchers from the State University of New York Upstate Medical University in Syracuse and the University of California, San Francisco, have found evidence that methadone treatment programs are ...
Type of Study Phase 2 clinical trial of TB treatment with pharmacokinetic and surrogate biomarker sub-studies Design Phase 2 multi-center, randomized, placebo-controlled, double blind clinical trial ...
This is a 58-year-old liver recipient with a history of possible TB as a teenager. Re-exacerbation of TB cannot be ruled out. Do we know the status of his purified protein derivative (PPD) skin test?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback